BiotechTube
Home/Pipeline/Takp-119

Takp-119

Atopic dermatitis (pruritus)

Phase 2Active

Key Facts

Indication
Atopic dermatitis (pruritus)
Phase
Phase 2
Status
Active
Company
Akaal Pharma

About Akaal Pharma

Australian biotech developing selective S1P1 modulators for dermatology and autoimmune indications.

View full company profile

Therapeutic Areas

ImmunologyDermatologyNeurology